SUBJECT: Exciting News for Pluralsight
Team,
Pluralsight has embarked on an exciting new chapter in our
evolution. We announced today that weve entered into a definitive agreement to be acquired by Vista Equity Partners. You can read the press release here.
If you are not familiar, Vista is a global investment firm focused exclusively on enterprise software, data and technology-enabled businesses with a proven
track record of helping management teams drive growth. They have pioneered an investment and operating model for market-leading SaaS companies with substantial untapped opportunity ahead of them. Through this partnership with Vista, we will be
positioned to move faster and be more agile, accelerate our strategic vision and further strengthen our leading market position through continued user growth.
Vistas support will enable us to accelerate our product roadmap, such as building hands-on experiences.
Ultimately, we believe we will be able to deliver deeper, more powerful solutions that help our customers adapt and thrive in the digital age. The sheer scale of how we can grow with Vista will take our company to a whole new level, creating more
opportunity for all of our authors.
You should experience minimal, if any, changes in how we work with you. Vista supports our strategic vision, shares
our belief in the transformative power of technology and technology skills, and we look forward to leveraging their expertise to further improve our operations and performance.
In terms of next steps, the transaction is expected to close in the first half of 2021. We are operating as usual. Upon completion of the proposed
transaction, we will continue to work with you to empower our customers to drive the next wave of innovation for their organizations.
Youre an
important member of the Pluralsight team, and we look forward to building upon our relationship.
Best,
Aaron
Additional Information and Where to Find It
Pluralsight, its directors and certain executive officers are participants in the solicitation of proxies from stockholders in connection with the acquisition
of Pluralsight (the Transaction). Pluralsight plans to file a proxy statement (the Transaction Proxy Statement) with the Securities and Exchange Commission (the SEC) in connection with the solicitation of proxies
in connection with the Transaction.
Aaron Skonnard, Gary Crittenden, Scott Dorsey, Arne Duncan, Ryan Hinkle, Leah Johnson, Timothy Maudlin, Frederick
Onion, Bradley Rencher, Bonita Stewart and Karenann Terrell, all of whom are members of Pluralsights Board of Directors, and James Budge, Pluralsights Chief Financial Officer, are participants in Pluralsights solicitation. Other
than Messrs. Skonnard and Onion, none of such participants owns in excess of one percent of the voting power of Pluralsights common stock. Mr. Skonnard may be deemed to own approximately 53.6 percent of the voting power of
Pluralsights capital stock, and Mr. Onion may be deemed to own approximately 4.2 percent of the voting power of Pluralsights capital stock. Additional information regarding such participants, including their direct or indirect
interests, by security holdings or otherwise, will be included in the Transaction Proxy Statement and other relevant documents to be filed with the SEC in connection with the Transaction. Information relating to the foregoing can also be found in
Pluralsights definitive proxy statement for its 2020 Annual Meeting of Stockholders (the 2020 Proxy Statement), which was filed with the SEC on March 18, 2020. To the extent that holdings of Pluralsights securities have
changed since the amounts printed in the 2020 Proxy Statement, such changes have been or will be reflected on Statements of Change in Ownership on Form 4 filed with the SEC.
Promptly after filing the definitive Transaction Proxy Statement with the SEC, Pluralsight will mail the definitive Transaction Proxy Statement and a WHITE
proxy card to each stockholder entitled to vote at the special meeting to consider the Transaction. STOCKHOLDERS ARE URGED TO READ THE TRANSACTION PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER